Terumo Corporation (TOKYO:4543) announced today that it
will expand its production facilities in Asia to meet
anticipated sales increases in the medium to long term,
based on its corporate growth strategy. Terumo Corporation
will establish a new factory in Vietnam, its second in the
country, as well as expand the production scale of existing
factories in Vietnam and the Philippines. The total amount
invested will be 15 billion yen.
The new factory in Vietnam will produce blood management
products such as blood bags to meet growing global demand,
especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture)
and the new Yamaguchi factory in Japan (operation to be
started in 2015), the existing factory in Vietnam will
expand the production scale of interventional systems
products, sales of which have been growing at a
double-digit pace. The company will also establish a new
production building at the existing factory in the
Philippines to cope with needed production increases of
syringes and needles.
To improve its global competitiveness, Terumo Corporation
is seeking to enhance the production capacity across all of
its three business areas: Cardiac & Vascular, General
Hospital, and Blood Management.
Terumo Corporation's global production system
Terumo Corporation is accelerating its growth globally, and
plans to increase the percent of production done outside
Japan in line with the growth in the share of net sales
outside Japan, which already account for over half of the
total. Accordingly, the company has positioned factories in
Asia as its global production center and is already
producing a broad range of products in China, the
Philippines, and Vietnam.
On another front, certain highly advanced and precise
production technologies are difficult to transfer outside
of Japan. The company has designated factories in Japan as
mother production factories that develop and refine core
manufacturing technologies to underpin product
improvement.
Terumo Corporation will continue to enhance its global
production system in factories in Asia and Japan to meet
growing global demand while increasing cost
competitiveness.
Factories Overview
1. Vietnam: a new factory to be established
In April 2012, Terumo BCT was established through the
integration of CaridianBCT and Terumo Transfusion,
following Terumo Corporation's acquisition of
CaridianBCT in April 2011. The company will establish a new
factory in Vietnam to produce blood management products to
meet growing global demand, especially in emerging
countries. The factory will be its sixth production
facilities of blood management products, following ones in
Japan, U.S., UK
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
TERUMO CORPORATION 
